Article, Oncology / 21.06.2023
Treating Lung Cancer with Antibody-Drug Conjugates: Advancing Clinical Trials and New Updates at ASCO 2023
Given that the relative survival rate of patients diagnosed with metastatic lung cancer is low, and that traditional chemotherapy and surgery are of limited efficacy, ADCs represent a potentially important treatment option....